Danimer Scientific

Danimer Scientific, Inc. operates as a next generation bioplastics company. It focuses on the development and production of biodegradable materials. The firm sells its products under the brand name Nodax. Its applications for biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles. The company was founded on January 13, 2014 and is headquartered in Bainbridge, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Danimer Scientific secures $130M loan, eyes profitability amid challenges

Danimer Scientific's Q4 2022 earnings call highlighted revenue figures, adjusted EBITDA losses, and strategic plans for profitability in 2023.
The company's strengths lie in its strong executive team, sustainability focus, key partnerships, and successful financing initiatives.
Challenges include cost estimates for projects, achieving profitability, managing off-take agreements, and balancing financial needs with shareholder interests.
Opportunities exist in the growing demand for sustainable materials, global brand partnerships, revenue growth, and market disruption for Danimer.

Danimer Scientific reports mixed Q1 results, eyes growth opportunities

Danimer Scientific's Q1 2023 performance showed mixed results with revenue decline but improved EBITDA loss and increased liquidity. The company's strengths lie in cost control, new commercial opportunities, and partnerships. Challenges include fluctuating canola prices and interest expenses, while opportunities include growth in PHA-based materials and positive business momentum.

Danimer Scientific reports revenue growth amidst challenges, eyes sustainability opportunities

Danimer Scientific's Q2 performance reflected revenue growth driven by PHA-based resin sales, despite facing a gross loss due to higher expenses.
The company's emphasis on innovation, sustainability, and government support positions them well in the market, despite financial challenges and geopolitical risks.
Opportunities in new product development, market expansion, and operational growth present avenues for Danimer to enhance its competitive position and drive future success.

Danimer Scientific reports Q3 revenue growth amidst sustainability focus

Danimer Scientific's Q3 performance showed revenue growth driven by PHA-based resin sales, despite challenges in managing costs.
The company's strategic strengths lie in securing significant awards and its commitment to sustainability initiatives.
While facing financial challenges, Danimer has opportunities for growth through upcoming funding and market demand for eco-friendly solutions.

Danimer Scientific reports Q4 losses but highlights industry successes

Danimer Scientific faces challenges with delays in commercial launches and financial losses in Q4 2023. However, the company's strengths lie in its successes in biodegradable plastics, partnerships with key players, and progress in plant completion and market expansion. Opportunities for growth exist in product development, partnerships, and market prospects.

Danimer Scientific reports robust Q1 performance amidst revenue challenges

Danimer Scientific's Q1 performance reflects strong growth in PHA revenues and promising commercial partnerships.
While facing short-term challenges from revenue headwinds, the company's operational improvements and financial support position it well for future opportunities.
Managing liquidity and focusing on customer demand forecasts will be key in navigating the path towards profitability and sustainable growth.

Danimer Scientific reports Q3 revenue challenges but strengthens sustainability focus

Danimer Scientific's Q3 performance reflects a mixed financial picture with revenue challenges but improved EBITDA losses and strong liquidity focus.
The company's strengths lie in its sustainability focus, commercial partnerships, and leadership's confidence in future growth prospects.
While facing debt and revenue challenges, Danimer Scientific has opportunities to enhance financial flexibility, capitalize on market demand for sustainable solutions, and expand its commercial reach.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Inuvo

NEW YORK , Nov. 20, 2024 /PRNewswire/ -- TerraNova Capital Equities, inc. (TerraNova), a leading financial advisory firm, is pleased to announce that its Structure Finance Group acted as sole advisor on three recent transactions: TerraNova Structured Finance Group acted as the sole advisor to Danimer Scientific, Inc. (NYSE: DNMR) on a $20 Million revolving credit facility.

TerraNova Capital Equities announces three transactions totaling $45 Million

Danimer Scientific, Inc. (NYSE:DNMR ) Q3 2024 Earnings Conference Call November 19, 2024 10:00 AM ET Company Participants Rich Altice - Interim CEO Mike Hajost - CFO Conference Call Participants Unidentified Company Representative Thank you, operator. Good morning, everyone, and thank you for joining us today on Danimer Scientific's 2024 Third Quarter Earnings Call.

Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript

Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $8. This compares to loss of $15.60 per share a year ago.

Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Tops Revenue Estimates

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its third quarter ended September 30, 2024. Richard N. Altice, Interim Chief Executive Officer of Danimer, commented, “We completed the third quarter in line with our expectations considering the temporary impact of Starbucks' reapportionment.

Danimer Scientific Announces Third Quarter 2024 Results

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its third quarter 2024 financial results before the market opens on Tuesday, November 19, 2024. A webcast and conference call will be held that same day at 10:00 a.m. Eastern Time to review the Company's third quarter results. The web.

Danimer Scientific Announces Release Date for Third Quarter 2024 Results

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or “Company”), a leading, next-generation biotechnology company focused on the production of biomaterials, announced today that, following approval by the Company's stockholders and its Board of Directors, the Company will effect a reverse stock split (“Reverse Stock Split”) of Danimer's Class A common stock, par value $0.0001 per share (“Common Stock”), at a ratio of 1-for-40 (the “Reverse Stock Split Ratio”), w.

Danimer Scientific Announces Intention to Complete a Reverse Stock Split

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced that, on September 27, 2024, the United States Court of Appeals for the Second Circuit affirmed the 2023 Order of the United States District Court for the Eastern District of New York dismissing a previously disclosed putative class action complaint captioned In r.

Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action Lawsuit

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation biotechnology company focused on the production of biodegradable materials, today announced that Richard Altice, a current Danimer director and former President and Chief Executive Officer of NatureWorks, has been named Interim Chief Executive Officer, effective immediately. Mr. Altice succeeds Stephen Croskrey, who previously announced his intention to retire after m.

Danimer Scientific Names Richard Altice Interim CEO

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer”), a leading, next-generation biotechnology company focused on the production of biodegradable materials, and Ningbo Homelink Eco-iTech Co. Ltd. (“Homelink”), a leading manufacturer of disposable tableware, have announced commercial launch of home compostable extrusion coating biopolymers made with Danimer's signature polyhydroxyalkanoate (PHA), Nodax®. Homelink's cups, coated with Nodax® PHA-based biopolymer, wil.

Ningbo Homelink Eco-iTech and Danimer Scientific Announce Commercial Launch of Home Compostable Extrusion Coating Biopolymer Based on PHA

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer”), a leading, next-generation biotechnology company focused on the production of biomaterials, announces an award from the U.S. Department of Defense via the Distributed Bioindustrial Manufacturing Program (DBIMP). Danimer Scientific has been awarded $1.36 million to develop plans for a facility to produce biobased polyols that can be converted into high-performance coatings for ships, marine vessels, and steel pi.

DoD Makes Award to Danimer Scientific via the Distributed Bioindustrial Manufacturing Program

Danimer Scientific (DNMR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

What Makes Danimer Scientific (DNMR) a New Buy Stock

Danimer Scientific, Inc (NYSE:DNMR ) Q2 2024 Results Conference Call August 8, 2024 4:30 PM ET Company Participants Blake Chamblee - Director of Financial Reporting Stephen Croskrey - Chairman and Chief Executive Officer Mike Hajost - Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities Operator Greetings. Welcome to the Danimer Scientific 2024 Second Quarter Earnings Call.

Danimer Scientific, Inc (DNMR) Q2 2024 Earnings Call Transcript

Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.38 per share a year ago.

Danimer Scientific, Inc. (DNMR) Reports Q2 Loss, Lags Revenue Estimates

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its second quarter ended June 30, 2024. Stephen E. Croskrey, Chief Executive Officer of Danimer, commented, “We completed the second quarter in line with our expectations considering the temporary impact of Starbucks' reapportionment of their.

Danimer Scientific Announces Second Quarter 2024 Results

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its second quarter 2024 financial results after the market closes on Thursday, August 8, 2024. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's second quarter results, discuss.

Danimer Scientific Announces Release Date for Second Quarter 2024 Results

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the completion of a previously announced pro-rata dividend distribution of warrants (“Dividend Warrants”) to holders of the Company's Class A Common Stock, par value $0.0001 per share (“Common Stock”), as of May 13, 2024 (“Record Date”). The stockholders of.

Danimer Scientific Completes Dividend Distribution of Warrants to Stockholders

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the production of biodegradable materials, announced that it received a notice from the New York Stock Exchange (“NYSE”) on May 21, 2024, that the Company is not currently in compliance with the NYSE's continued listing standard requiring listed-company stock to maintain an average closing price of not less than $1.00 per share over a pe.

Danimer Scientific Receives Continued Listing Standard Notice from NYSE

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that Stephen E. Croskrey has informed the Board of Directors that he will retire as Chief Executive Officer not later than the end of this calendar year. Mr. Croskrey's employment contract expires at the end of 2024 following nine years leading Danimer's mission to.

Danimer Scientific Announces Steve Croskrey Retirement and Related Changes to the Company's Board of Directors

Danimer Scientific, Inc. (NYSE:DNMR ) Q1 2024 Results Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Blake Chamblee - Director of Financial Reporting Stephen Croskrey - Chairman and Chief Executive Officer Mike Hajost - Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities Dan Rizzo - Jefferies LLC Operator Greetings. Welcome to the Danimer Scientific 2024 First Quarter Earnings Call.

Danimer Scientific, Inc. (DNMR) Q1 2024 Earnings Call Transcript

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its first quarter ended March 31, 2024. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, “We completed the first quarter in line with our expectations. However, we are facing near term headwinds into our second.

Danimer Scientific Announces First Quarter 2024 Results

BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of PHA biopolymers, is unveiling new commercial applications and branding during NPE 2024, North America's largest plastics tradeshow, taking place this week in Orlando, FL. A more perfect polymer™ takes center stage at NPE 2024. Danimer's signature PHA, Nodax®, represents a more perfect polymer revolution.

Danimer Scientific Reveals New Branding and New Applications Based on PHA During NPE 2024

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced a proposed pro-rata dividend distribution of warrants (“Dividend Warrants”) to holders of the Company's Class A Common Stock, par value $0.0001 per share (“Common Stock”) as of May 13, 2024 (“Record Date”). Subject to the Company's stockholders approving a p.

Danimer Scientific Announces Proposed Pro-Rata Distribution of Warrants to Purchase Common Stock

Danimer Scientific (DNMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Danimer Scientific, Inc. (DNMR) Report Negative Q1 Earnings? What You Should Know

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2024 financial results after the market closes on Tuesday May 7, 2024. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's first quarter results, discuss recent.

Danimer Scientific Announces Release Date for First Quarter 2024 Results

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today, that on April 19, 2024, it entered into an asset-based revolving credit and security agreement with Mountain Ridge Capital secured primarily by the Company's accounts receivable and inventory. The credit and security agreement provides for borrowings un.

News for Danimer Scientific Stock (DNMR)